Open AccessMolecular Subtypes and Tumor Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer
Author(s) -
Seung Il Kim,
Joohyuk Sohn,
Ja Seung Koo,
Seho Park,
Hyung Seok Park,
ByeongWoo Park
Publication year - 2010
Publication title -
oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.987
H-Index - 98
eISSN - 1423-0232
pISSN - 0030-2414
DOI - 10.1159/000322192
Subject(s) - taxane , anthracycline , chemotherapy , breast cancer , medicine , trastuzumab , neoadjuvant therapy , oncology , regimen , triple negative breast cancer , cancer , pathology
Pathologic complete response (pCR) is the most predictive factor for patients with neoadjuvant chemotherapy and we investigated the rate of pCR according to molecular subtypes defined by immunohistochemical staining.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom